April 18, 2017 / 8:34 PM / in 3 months

BRIEF-Argos Reports interim results of the ADAPT trial

1 Min Read

April 18 (Reuters) - Argos Therapeutics Inc:

* Argos reports interim results of the ADAPT trial and provides perspective on decision to continue the trial

* Argos Therapeutics Inc- continues to analyze data from trial and plans to meet with fda in may 2017

* Argos Therapeutics Inc- currently believes based on data it has reviewed that trial should be continued until completion Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below